43 filings
8-K
TSRX
Trius Therapeutics Inc
11 Sep 13
Completion of Acquisition or Disposition of Assets
12:00am
8-K
TSRX
Trius Therapeutics Inc
6 Aug 13
Trius Therapeutics Reports Second Quarter 2013 Financial Results
12:00am
8-K
TSRX
Trius Therapeutics Inc
1 Aug 13
Entry into a Material Definitive Agreement
12:00am
8-K
TSRX
Trius Therapeutics Inc
25 Jul 13
Entry into a Material Definitive Agreement
12:00am
8-K
TSRX
Trius Therapeutics Inc
24 May 13
Departure of Directors or Certain Officers
12:00am
8-K
zyxcp4
7 May 13
Trius Therapeutics Reports First Quarter 2013 Financial Results
12:00am
8-K
7lrez9dr7c bpr1h
3 Apr 13
Trius Appoints Seth Fischer to Its Board of Directors
12:00am
8-K
907yhgr93j902pc9juq
25 Mar 13
Trius Announces Positive Results from Establish 2 Study of
12:00am
8-K
gczyme nrnmxf7
13 Mar 13
Departure of Directors or Certain Officers
12:00am
8-K
ghsr9w7kgs k0biqqn
12 Mar 13
Trius Therapeutics Reports 2012 Fourth Quarter and Full Year 2012 Financial Results
12:00am
8-K
8a01dhl1my9aa2bdjf
18 Jan 13
Trius Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
12:00am
8-K
ub0jd
7 Jan 13
Tedizolid Receives Qualified Infectious Disease Product (Qidp) Designation from Fda
12:00am
8-K
d2tlm3ex
12 Dec 12
Other Events
12:00am
8-K
kapi7m 8g8
5 Nov 12
Trius Therapeutics Reports 2012 Third Quarter Financial Results
12:00am
8-K
v9nqlcut5s8g40gyxx
9 Oct 12
Other Events
12:00am
8-K
d0n1iing3nb1nk ghsy
31 Aug 12
Trius Therapeutics Secures a $25 Million Committed Equity
12:00am
8-K
om6ypy1j5ufcpyhp
6 Aug 12
Trius Therapeutics Reports 2012 Second Quarter Financial Results
12:00am
8-K
s37h17jbdf9o4f3r
23 May 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
5r3ldhum8i9m
8 May 12
Trius Therapeutics Reports First Quarter 2012 Financial Results
12:00am
8-K
mjgz227s8swd
12 Apr 12
Departure of Directors or Certain Officers
12:00am